New skin cancer drug is approved

Published in Cancer In The News

New skin cancer drug is approved
The first drug to extend survival rates for people with advanced melanoma has got the green light from Australian regulators.

The Therapeutics Goods Administration has approved Yervoy to treat patients with inoperable melanoma who have not responded to conventional therapies or cannot tolerate other drugs.

Until now, no drug has effectively prolonged the life of patients with advanced melanoma.

Australia is the first country to register Yervoy since the US Food and Drug Administration approved it in March.

The intravenous treatment uses the body’s immune system to help detect and destroy cancer

 

Cancer in the News is an edited summary of news items in daily national and capital city newspapers. Produced by Cancer Council Australia, it aims to keep stakeholders up-to-date on media reporting of cancer. Cancer in the News does not necessarily represent the views of Cancer Council Australia.